The Role of Tumor Associated Macrophages in Hepatocellular Carcinoma

Citations Over TimeTop 10% of 2021 papers

Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and represents a classic paradigm of inflammation-related cancer. Various inflammation-related risk factors jointly contribute to the development of chronic inflammation in the liver. Chronic inflammation, in turn, leads to continuous cycles of destruction-regeneration in the liver, contributing to HCC development and progression. Tumor associated macrophages are abundant in the tumor microenvironment of HCC, promoting chronic inflammation and HCC progression. Hence, better understanding of the mechanism by which tumor associated macrophages contribute to the pathogenesis of HCC would allow for the development of novel macrophage-targeting immunotherapies. This review summarizes the current knowledge regarding the mechanisms by which macrophages promote HCC development and progression, as well as information from ongoing therapies and clinical trials assessing the efficacy of macrophage-modulating therapies in HCC patients.

Related Papers

• → Role of the tumor microenvironment in tumor progression and the clinical applications (Review)(2016)319 cited
• → Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression(2018)84 cited
• → The First Tianjin, China Forum on Tumor Microenvironment(2011)6 cited
• → HCC-Mark: a simple non-invasive model based on routine parameters for predicting hepatitis C virus related hepatocellular carcinoma(2020)3 cited
• → Improving prognosis of patients with very early hepatocellular carcinoma: How far are we going?(2020)1 cited